drugset
drugset / Trial / NCT02326662

Neural Stem Cell Transplantation in Traumatic Spinal Cord Injury

NCT02326662 ↗

Phase 1/2 Unknown 30 enrolled Federal Research Clinical Center of Federal Medical & Biological Agency, Russia Novagenesis Foundation · collabOphiuchus Technologies AG · collab
Non-randomizedFactorialOpen-labelTreatment

Summary

This research investigates the use of autologous neural stem cells in patients with complete traumatic spinal cord injury.

Timeline

Start
2014-07
Primary completion
2018-10
Completion
2018-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Autologous Stem Cell Transplantation Cell therapy — Other

Indications

spinal cord injury